stella
beta
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer — Stella
Recruiting
Back to Metastatic Castration Resistant Prostate Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(11 sites)
Australia
GenesisCare North Shore (Oncology), Sydney, New South Wales
Sydney Adventist Hospital, Sydney, New South Wales
Cancer Research SA, Adelaide, South Australia
Southern Oncology Clinical Research Unit, Adelaide, South Australia
Icon Cancer Centre South Brisbane, Brisbane
Show all 11 locations
View full record on ClinicalTrials.gov